Alcyone Lifesciences, DNAtrix form drug delivery alliance; Oral steroids found ineffective at speeding recovery following surgery;

> Alcyone Lifesciences and DNAtrix are in an alliance. DNAtrix will utilize Alcyone's MEMS Cannula targeted delivery platform for the intratumoral delivery of its lead brain cancer candidate. More

> A study in the Journal of the American Medical Association found that oral steroids are likely ineffective at speeding recovery from lumbar radiculopathy. More

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.